Catalent Inc. [CTLT] stock prices are up 0.43% to $60.71 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CTLT shares have gain 0.70% over the last week, with a monthly amount drifted -0.02%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Catalent Inc. [NYSE: CTLT] stock has seen the most recent analyst activity on November 16, 2023, when Robert W. Baird upgraded its rating to a Outperform and also boosted its price target to $53 from $45. Previously, Argus upgraded its rating to Buy on September 05, 2023, and kept the price target unchanged to $62. On July 20, 2023, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $43 on the stock. Jefferies downgraded its rating to a Hold and reduced its price target to $44 on June 14, 2023. JP Morgan downgraded its rating to Neutral for this stock on May 22, 2023, and downed its price target to $45. In a note dated May 15, 2023, Deutsche Bank downgraded an Hold rating on this stock and revised its target price from $55 to $29.
The stock price of Catalent Inc. [CTLT] has been fluctuating between $31.80 and $61.20 over the past year. Currently, Wall Street analysts expect the stock to reach $76.4 within the next 12 months. Catalent Inc. [NYSE: CTLT] shares were valued at $60.71 at the most recent close of the market. An investor can expect a potential return of 25.84% based on the average CTLT price forecast.
Analyzing the CTLT fundamentals
The Catalent Inc. [NYSE:CTLT] reported sales of 4.38B for trailing twelve months, representing a surge of 21.82%. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.27 and Total Capital is -0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 60.50 points at the first support level, and at 60.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 60.82, and for the 2nd resistance point, it is at 60.92.
Ratios To Look Out For
It’s worth pointing out that Catalent Inc. [NYSE:CTLT]’s Current Ratio is 2.52. In addition, the Quick Ratio stands at 1.96 and the Cash Ratio stands at 0.28. Considering the valuation of this stock, the price to sales ratio is 2.51, the price to book ratio is 3.05.
Transactions by insiders
Recent insider trading involved McErlane David, Group President, Biologics, that happened on Sep 26 ’24 when 1994.0 shares were sold. Officer, McErlane David completed a deal on Sep 26 ’24 to buy 2168.0 shares. Meanwhile, Pres. BioProduct Delivery, CoS Hopson Ricky sold 662.0 shares on Aug 02 ’24.
